Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

ZEOX Relative to the S&P 500

ZEOX Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Zeo ScientifiX Inc. (OTCMKT:ZEOX) seasonal charts above shows that a Buy Date of June 8 and a Sell Date of September 12 has resulted in a geometric average return of 33.26% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 72.92% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

ZEO ScientifiX, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of degenerative diseases. Its product is Zofin, which is an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs, without the addition or combination of any other substance or diluent. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Davie, FL.

To download ZEOX seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: ZEOX